Piper Jaffray Companies reiterated their buy rating on shares of athenahealth, Inc. (NASDAQ:ATHN) in a research report report published on Tuesday, October 17th. They currently have a $167.00 price target on the health services provider’s stock.
Other equities research analysts have also recently issued research reports about the company. TheStreet raised athenahealth from a c rating to a b- rating in a research report on Thursday, July 20th. BidaskClub raised athenahealth from a hold rating to a buy rating in a research report on Saturday, June 24th. Citigroup Inc. reissued a buy rating and issued a $169.00 price objective (up from $163.00) on shares of athenahealth in a research report on Monday, July 10th. SunTrust Banks, Inc. reaffirmed a buy rating and issued a $150.00 target price on shares of athenahealth in a research report on Monday, July 17th. Finally, Robert W. Baird reaffirmed a buy rating and issued a $170.00 target price on shares of athenahealth in a research report on Thursday, August 31st. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $144.30.
Shares of athenahealth (NASDAQ:ATHN) traded up 2.73% during trading on Tuesday, hitting $126.20. 150,580 shares of the stock traded hands. The firm has a market cap of $5.04 billion, a PE ratio of 160.15 and a beta of 1.76. athenahealth has a 52-week low of $90.11 and a 52-week high of $158.66. The company’s 50 day moving average is $124.53 and its 200 day moving average is $130.71.
athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.06. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The firm had revenue of $304.60 million for the quarter, compared to the consensus estimate of $310.52 million. During the same quarter in the prior year, the company posted $0.60 earnings per share. The firm’s revenue was up 10.1% on a year-over-year basis. On average, equities research analysts predict that athenahealth will post $2.00 EPS for the current year.
WARNING: This piece was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2017/10/27/athenahealths-athn-buy-rating-reaffirmed-at-piper-jaffray-companies.html.
In other news, CEO Jonathan Bush sold 4,000 shares of the company’s stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $143.31, for a total transaction of $573,240.00. Following the completion of the sale, the chief executive officer now directly owns 319,807 shares in the company, valued at approximately $45,831,541.17. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Brandon H. Hull sold 800 shares of the company’s stock in a transaction on Friday, October 20th. The shares were sold at an average price of $130.00, for a total value of $104,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 16,583 shares of company stock valued at $2,236,924. Corporate insiders own 3.20% of the company’s stock.
Institutional investors have recently bought and sold shares of the company. Elliott Management Corp acquired a new position in shares of athenahealth during the 2nd quarter worth $52,706,000. UBS Asset Management Americas Inc. raised its holdings in shares of athenahealth by 33.2% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 30,536 shares of the health services provider’s stock worth $4,292,000 after buying an additional 7,605 shares in the last quarter. Scout Investments Inc. raised its holdings in shares of athenahealth by 67.2% during the 2nd quarter. Scout Investments Inc. now owns 115,663 shares of the health services provider’s stock worth $16,256,000 after buying an additional 46,507 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of athenahealth by 1.7% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 72,918 shares of the health services provider’s stock worth $10,249,000 after buying an additional 1,222 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. raised its holdings in shares of athenahealth by 6.2% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 170,978 shares of the health services provider’s stock worth $24,031,000 after buying an additional 9,960 shares in the last quarter.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.